Nucleic Acids Research, 1992, Vol. 20, No. 12 3099-3104
© 1992
MOLECULAR BIOLOGY |
The liver-specific promoter of the human insulin-like growth factor II gene is activated by CCAAT/enhancer binding protein (C/EBP)
Laboratory for Physiological Chemistry, State University of Utrecht Vondellaan 24a, 3521GG Utrecht, The Netherlands
* To whom correspondence should be addressed
Received March 2, 1992. Revised May 14, 1992. Accepted May 14, 1992.
The human gene coding for insulin-like growth factor II (IGF-II) contains four promoters (P1 - P4), that are subjected to tissue-specific and development-dependent regulation. Expression of promoter P1 Is detected only in adult liver tissue, whereas promoter P3 is the major IGF-II promoter in fetal liver and is further expressed in other fetal tissues and in adult non-hepatic tissues. C/EBP is a tissue- and development-specific transcription factor that is expressed predominantly in adult liver, adipose tissue and lung. The effect of C/EBP on the expression of constructs containing IGF-II promoter P1 or P3 linked to the luciferase gene was investigated in cotransfection assays using Hep3B cells. We found that promoter P1 can be activated by C/EBP, whereas this transcription factor has no effect on the expression of promoter P3. By gel retardation and DNasel footprinting it was demonstrated that C/EBP can bind to a region of P1 located between 82 and 109 basepairs upstream of the cap site. Furthermore, we showed that deletion of this C/EBP binding region strongly reduces the ability of C/EBP to stimulate transcription from P1. These results indicate that C/EBP is a major component in the specific activation of the human IGF-II promoter P1 in adult liver.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
I. Netchine, S. Rossignol, M.-N. Dufourg, S. Azzi, A. Rousseau, L. Perin, M. Houang, V. Steunou, B. Esteva, N. Thibaud, et al. 11p15 Imprinting Center Region 1 Loss of Methylation Is a Common and Specific Cause of Typical Russell-Silver Syndrome: Clinical Scoring System and Epigenetic-Phenotypic Correlations J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3148 - 3154. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. D. Rees, S. M. Hay, N. C. Fontanier-Razzaq, C. Antipatis, and D. N. Harries Expression of the Growth Arrest Genes (GAS and GADD) Changes during Organogenesis in the Rat Fetus J. Nutr., August 1, 1999; 129(8): 1532 - 1536. [Abstract] [Full Text] |
||||
![]() |
Y. Kitami, T. Fukuoka, K. Hiwada, and T. Inagami A High Level of CCAAT-Enhancer Binding Protein-{delta} Expression Is a Major Determinant for Markedly Elevated Differential Gene Expression of the Platelet-Derived Growth Factor-{alpha} Receptor in Vascular Smooth Muscle Cells of Genetically Hypertensive Rats Circ. Res., January 22, 1999; 84(1): 64 - 73. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. T. Rodenburg, P. E. Holthuizen, and J. S. Sussenbach A Functional Sp1 Binding Site Is Essential for the Activity of the Adult Liver-Specific Human Insulin-Like Growth Factor II Promoter Mol. Endocrinol., February 1, 1997; 11(2): 237 - 250. [Abstract] [Full Text] |
||||



